Research Papers:

H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC

Marianeve Carotenuto, Pasqualino De Antonellis, Lucia Liguori, Giovanna Benvenuto, Daniela Magliulo, Alessandro Alonzi, Cecilia Turino, Carmela Attanasio, Valentina Damiani, Anna Maria Bello, Fabiana Vitiello, Rosa Pasquinelli, Luigi Terracciano, Antonella Federico, Alfredo Fusco, Jamie Freeman, Trevor C. Dale, Charles Decraene, Gennaro Chiappetta, Francovito Piantedosi, Cecilia Calabrese and Massimo Zollo _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2014; 5:5736-5749. https://doi.org/10.18632/oncotarget.2169

Metrics: PDF 2821 views  |   HTML 2587 views  |   ?  


Marianeve Carotenuto1,2, Pasqualino De Antonellis1,2, Lucia Liguori1,2, Giovanna Benvenuto3, Daniela Magliulo1,2, Alessandro Alonzi1,2, Cecilia Turino4, Carmela Attanasio1,2, Valentina Damiani1,2, Anna Maria Bello1,2, Fabiana Vitiello5, Rosa Pasquinelli6, Luigi Terracciano7, Antonella Federico8, Alfredo Fusco8, Jamie Freeman9, Trevor C. Dale9, Charles Decraene10,11, Gennaro Chiappetta6, Francovito Piantedosi5, Cecilia Calabrese4 and Massimo Zollo1,2,12

1 Centro di Ingegneria Genetica e Biotecnologie Avanzate (CEINGE), Naples, Italy

2 Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università ‘Federico II’ di Naples, Italy

3 Stazione Zoologica Anthon Dohrn, Villa Comunale, Naples, Italy

4 Dipartimento di Scienze Cardiotoraciche e Respiratorie, Clinica Seconda Università degli Studi di Napoli, Naples, Italy

5 Dipartimento di Pneumologia e Tisiologia, Day Hospital Pneumologia e Pneumoncologico, AORN Vincenzo Monaldi, Naples, Italy

6 Functional Genomic Unit, National Cancer Institute, Fondazione G. Pascale, Naples, Italy

7 Institute of Pathology, Molecular Pathology Division, University of Basel, Switzerland

8 Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto Di Endocrinologia e Oncologia Sperimentale del CNR, Naples, Italy

9 School of Biosciences, Cardiff University, Museum Avenue, Cardiff, Wales, UK

10 Translational Research Dept, Institut Curie, Centre de recherche, Paris, France

11 CNRS, UMR144, Paris, France

12 Azienda Ospedaliera Federico II, DAI Medicina Trasfusionale, Naples, Italy


Massimo Zollo1, email:

Keywords: h-Prune, lung cancer, diagnostic marker, WNT/β-catenin signalling, Gsk-3β, Wnt3a

Received: June 18, 2014 Accepted: July 4, 2014 Published: July 5, 2014


H-Prune  hydrolyzes short-chain polyphosphates (PPase activity) together with an hitherto cAMP-phosphodiesterase (PDE), the latest influencing different human cancers by its overexpression. H-Prune promotes cell migration in cooperation with glycogen synthase kinase-3 (Gsk-3β). Gsk-3β is a negative regulator of canonical WNT/β-catenin signaling. Here, we investigate the role of Gsk-3β/h-Prune complex in the regulation of WNT/β-catenin signaling, demonstrating the h-Prune capability to activate WNT signaling also in a paracrine manner, through Wnt3a secretion. In vivo study demonstrates that h-Prune silencing inhibits lung metastasis formation, increasing mouse survival. We assessed h-Prune levels in peripheral blood of lung cancer patients using ELISA assay, showing that h-Prune is an early diagnostic marker for lung cancer. Our study dissects out the mechanism of action of h-Prune in tumorigenic cells and also sheds light on the identification of a new therapeutic target in non-small-cell lung cancer.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2169